Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

LYEL

Lyell Immunopharma Inc

May 08 • 04:00PM ET

19.33

-0.73 -3.64 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: ALLO IPSC SANA NKTX FATE

| Held by: VTI VXF SCHA IBB VHT AVSC DFAS DFMC SCHB PRFZ

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-12.74	Insider Own	65.15%	Shs Outstand	23.33M	Perf Week	-7.20%
Market Cap	451.05M	Forward P/E	-	EPS next Y	-8.46	Insider Trans	6.75%	Shs Float	8.13M	Perf Month	-18.95%
Enterprise Value	245.88M	PEG	-	EPS next Q	-1.10	Inst Own	14.40%	Short Float	15.18%	Perf Quarter	-14.88%
Income	-246.41M	P/S	15035.00	EPS this Y	53.13%	Inst Trans	8.21%	Short Ratio	12.88	Perf Half Y	16.87%
Sales	0.03M	P/B	1.65	EPS next Y	-12.40%	ROA	-63.15%	Short Interest	1.23M	Perf YTD	-37.20%
Book/sh	11.73	P/C	1.78	EPS next 5Y	23.93%	ROE	-80.76%	52W High	45.00 -57.04%	Perf Year	125.82%
Cash/sh	10.89	P/FCF	-	EPS past 3/5Y	-2.70% 0.99%	ROIC	-78.69%	52W Low	7.65 152.68%	Perf 3Y	-57.98%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-92.48% -65.85%	Gross Margin	-33545.16%	Volatility	5.89% 6.93%	Perf 5Y	-
Dividend TTM	-	EV/Sales	8196.00	EPS Y/Y TTM	49.06%	Oper. Margin	-620790.32%	ATR (14)	1.55	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	7.23	Sales Y/Y TTM	-52.31%	Profit Margin	-794858.06%	RSI (14)	37.61	Recom	1.20
Dividend Gr. 3/5Y	- -	Current Ratio	7.23	EPS Q/Q	68.79%	SMA20	-13.35%	Beta	-0.06	Target Price	42.20
Payout	-	Debt/Eq	0.18	Sales Q/Q	-71.43%	SMA50	-12.35%	Rel Volume	0.65	Prev Close	20.06
Employees	161	LT Debt/Eq	0.14	Earnings	Mar 12 AMC	SMA200	-4.20%	Avg Volume	95.85K	Price	19.33
IPO	Jun 17, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	-219.44% -60.78%	Trades		Volume	62,012	Change	-3.64%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)